A B S T R A C T The acute effects of chlorothiazide (CTZ) on total (TSCA) and ionized (SCA2') serum calcium concentrations were studied in three groups of people: (a) eight subjects with normal parathyroid function; (b) six patients with hypoparathyroidism; and (c) two patients with hyperparathyroidism. Most subjects were studied on four occasions; at least 3 days intervened between studies on an individual subject. During each experiment the subject received an i.v. infusion of 5% dextrose in water at 1 ml/min from 8 a.m. to 4 p.m. Additions to the infusions were (a) none; (b) CTZ to deliver 3.33 mg/kg/h; (c) parathyroid extract to deliver 1 U/kg/h; or (d) both CTZ and parathyroid extract at the rates previously indicated. CTZ, when used, was added to the infusion at 10 a.m., parathyroid extract at 8 a.m. When CTZ was infused, the diureticinduced losses of Na and water were replaced by i.v. infusion. In normal subjects 2 h after the start of CTZ infusion, there was a transient increase in SCA +2 which coincided in time of day with a transient decrease in SCA+2 in control experiments. At that time of day SCA+2 was 4.18±0.12 mg/100 ml in control experiments and 4.56±0.08 in experiments with CTZ, P < 0.025. The corresponding values for (TSCA) were 9.32±0.15 and 9.80+0.30, P < 0.01. Such differences were not observed in the group with hypoparathyroidism. In the two patients with hyperparathyroidism, CTZ produced sustained increases in TSCA and SCA+'. In normal subjects and those with hypoparathyroidism, CTZ plus parathyroid extract infusion resulted in sustained increases in both
INTRODUCTION
The mechanism of thiazide-induced hypercalcemia has been the subject of numerous investigations (1) (2) (3) (4) (5) (6) (7) (8) . Although hypercalcemia has been noticed primarily in patients with high rates of bone turnover (2, 3, 5) , significant increases in serum calcium concentration were also reported in normal individuals treated with thiazide diuretics (1, 7) .
Because changes in total serum calcium concentration may reflect alterations in serum protein concentration without real changes in calcium metabolism (9) , the direct measurement of serum ionized calcium is most desirable for an accurate determination of changes in calcium homeostasis. In this regard the correction of the measured total calcium concentration for the changes in serum protein concentration may not be entirely satisfactory since thiazides may alter the binding power of serum proteins for calcium (6) . Furthermore, changes in the ultrafiltrable calcium concentration may not necessarily correlate closely with changes in ionized calcium concentration (9) and therefore cannot be used as a perfect substitute for ionized calcium.
Several mechanisms by which thiazides may affect calcium metabolism are worth brief comment. Contraction of the extracellular fluid volume may affect serum calcium concentration both by increasing the protein bound fraction and by augmenting tubular reabsorption of calcium (2, 5, 7, 10) . In addition thiazides may act directly on the kidney to enhance tubular reabsorption of calcium ( 11). Mobilization of mineral from the bone has been proposed as another mechanism for the thiazide-induced increase in serum calcium (3, 5) . This mechanism was considered to be most effective in states of rapid bone turnover, such as hyperparathyroidism, or during an intake of large dose of vitamin D (2, 3, 5) .
0C-CONTROL (N=8)
All the previously reported findings in man were during chronic administration of thiazide diuretics and without a rigid replacement regimen for the urinary losses of sodium and water. The present study was 
The acute effect of CTZ on TSCA in hypoparathyroid patients.
vacutainers (Becton, Dickinson, and Co., Rutherford, N.J.), every 2 h, at 8 :00 a.m., 10 :00 a.m., 12 noon, 2 :00 p.m., and 4:00 p.m. The 8:00 a.m. specimen was obtained after breakfast whereas the 12 noon specimen was withdrawn before lunch. All serum samples were assayed for creatinine, calcium, phosphorus, magnesium, sodium, and potassium by methods reported previously from this laboratory (12) . Serum pH was measured in all serum specimens by a Corning Blood pH nmeter (Corning Glass Works, Orange, Calif.). Serum The system that we used consisted of a digital expandedscale pH/mV meter, a Calomel reference electrode, a calcium exchange electrode, and a gear driven syringe pump. The only refinement was additional metal shielding (de- 
RESULTS
CTZ infusion. The administration of CTZ did not significantly alter serum pH, total protein, albumin, phosphorus, magnesium, sodium, potassium, and creatinine concentrations in all patients. In group 1 there was no significant difference between the corresponding SCA"2 during the control and the CTZ infusion, with the exception of the values obtained 2 h after the begining of the CTZ infusion at 12:00 noon. The experimental value was significantly higher than the corresponding control (P < 0.025) as well as the preinfusion value, P < 0.05 (Fig. 1) . Thus the transient increment in SCA"2 did not only represent a relative change due to a decrease in the control values, but also an absolute increase in relation to the preinfusion values. Measurement of total serum calcium concentration (TSCA) showed a transient increase in serum concentration at 12:00 noon only in relation to the corresponding control infusion values (Fig. 2) . In patients with hypoparathyroidism treated with vitamin D (Group 2), no difference could be noticed between the SCA+2 and TSCA during the control and the CTZ infusions ( Fig. 3 and  4) . The two patients with hyperparathyroidism (group 3) showed a sustained elevation in SCA"2 during CTZ infusion above the values recorded during the control infusion (Fig. 5) .
Urinary excretion rates of calcium, magnesium, phosphorus, and sodium during CTZ infusions were significantly higher than the corresponding values during the control infusions and higher than the preinfusion values in both groups 1 and 2 (Tables I, II, III and IV) . Compared with PTH infusion only.
There were no significant changes in creatinine clearance rates. The urinary excretion rates of all ions in group 3 during CTZ infusion showed similar changes but they were not statistically significant.
Intravenous adminlistration of CTZ duiring contin nouis infusion of parathyroid hormonie (PTH). The i.v. administration of CTZ during continuous PTH infusion was associated with a significant increase in serum calcium concentrations above the corresponding values recorded during PTH infusion alone. A sustained increase in the SCA+2 and TSCA was exhibited by both the normoparathyroid and hypoparathyroid patients ( Fig. 6 and 7) . In the normoparathyroid patients the maximal increase in SCA+2 was noticed at periods during which CTZ had no effect on serum calcium. The most striking hypercalcemic response was observed in group 1 in which the mean concentration of ionized calcium exceeded the upper normal value of 5 mg/100 ml.
During PTH infusions urinary excretion rates of calcium and magnesium were significantly lower and those of phosphorus and sodium were significantly higher, than the corresponding excretion rates during control infusions, both in the normoparathyroid and the hypoparathyroid individuals (Tables I and III) .
There were no significant differences between creatinine clearance rates. There were no significant changes in serum pH, total protein, albumin, phosphorus, magnesium, sodium, and potassium during PTH infusion.
The i.v. administration of CTZ blunted or abolished both the hypocalciuric and the hypomagnesiuric actions of PTH but enhanced its natriuretic and the phosphaturic actions, both in the normoparathyroid and the hypoparathyroid individuals (Tables I, II, III, and IV ference between the normoparathyroid and hypoparathyroid individuals in their response to CTZ infusion is not well understood. Obviously the presence of parathyroid activity might be one of the factors upon which the transient increase in serum calcium was dependent. Such a dependence could either involve stimulation of PTH secretion (15) or potentiation of its peripheral action by CTZ (3). Both possibilities were considered in previous studies (3) (4) (5) . The hypercalcemic action of PTH is a result of its skeletal mobilization of calcium and increased gastrointestinal absorption of calcium (16) (17) (18) (19) . The results of our study confirmed the previously reported hypocalciuric effect of PTH in hypoparathyroid patients (17) and demonstrated it also in normal subjects. By contrast to the occurrence of hypocalciuria after chronic administration of thiazide diuretics (20, 21) in the present study the acute administration of CTZ caused a pronounced calciuresis both in the normoparathyroid and hypoparathyroid individuals. Similar response to i-v. CTZ was also reported by other investigators (22, 23) . Furthermore, in the present study the thiazide diuretics blunted substantially the hypocalciuric effect of exogenous PTH. Thus the renal actions of CTZ which tended to reduce serum calcium concentration obviously could not account for the observed rise in serum calcium and in fact could play a role in blunting the hypercalcemic action of thiazides in the normal subjects.
Although PTH has been shown to effect an increase in the gastrointestinal absorption of calcium, and theoretically CTZ could act by enhancing this effect, the present data did not provide sufficient evidence either to support or to exclude this possibility. The onset of PTH's actions on the bowel is delayed and was reported to start 5 or more h after the administration of the hormone (19) . Long-term thiazide therapy failed to alter gastrointestinal absorption of calcium in patients with recurrent renal calculi (24) , whereas the acute effect is unknown.
CTZ infusion caused a phosphaturia both in normoparathyroid and in hypoparathyroid individuals in the presence and in the absence of PTH. A drop in serum phosphorus could induce a reciprocal increase in serum calcium. However, the fact that no changes were noticed in serum phosphorus concentration makes this possibility unlikely.
In view of these considerations, and the rapidity of the hypercalcemic response, it is most likely that the increase in TSCA and SCA"2 in our patients was primarily due to a thiazide-induced enhancement of PTH action on the bone. We were unable to demonstrate a hypercalcemic effect in hypoparathyroid patients treated with large doses of vitamin D, which has been reported by other investigators during chronic administration of thiazide diuretics (3, 5) . However, it has to be emphasized that the results of our study are limited to the acute actions of CTZ and may not bear on the effects of chronic administration of thiazide diuretics. Furthermore, the occurrence of hypercalciuria during the acute administration of CTZ might have blunted a possible hypercalcemic action of thiazides in the hypoparathyroid patients.
